Thanks treed you know I have read it a number of times and now just read it again after your comment and it makes a lot more sense now. I think I was focusing on the wrong thing and not taking that dot point into consideration. Basically they are saying from these 12 patients they have the info required to confidently run the trial.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-379
-
- There are more pages in this discussion • 469 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |